HIGHLIGHTS
- who: Sarah Holper et al. from the Department of Medicine-The Royal Melbourne Hospital, University of Melbourne, Parkville, Australia have published the research: Tau as a Biomarker of Neurodegeneration, in the Journal: (JOURNAL)
- how: Challenges with the interpretation of these results are discussed as well as possible solutions to these challenges such as the utility of combined biomarker analyses.
- future: Research including head-to-head comparisons to existing biomarkers are needed to determine their role in the diagnosis and management of patients with tauopathies.
SUMMARY
In the CNS, the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.